Mediland Pharm Limited announced earnings results for the full year ended June 30, 2021. For the full year, the company announced sales was AUD 1.157 million compared to AUD 23.298 million a year ago. Net loss was AUD 6.430 million compared to AUD 5.109 million a year ago. Basic loss per share from continuing operations was AUD 0.0203 compared to AUD 0.0163 a year ago.